Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.
J Biomed Mater Res B Appl Biomater. 2018 Apr;106(3):1307-1316. doi: 10.1002/jbm.b.33937. Epub 2017 Jun 23.
Parenchymal transection during hepatobiliary surgery can disrupt small vasculature or bile ducts, which could be managed difficultly. Sealants are helpful tools to achieve better hemostasis. The aim of this study is to analyze the hemostatic efficiency of four modern sealants in a porcine model. In this study, 40 landrace pigs were assigned equally to the control (without sealant) and four sealant groups. Standardized liver resection and splenic lesions were performed and left without using sealant (control) or treated with one of the following sealants: TachoSil , Tissucol Duo , Coseal , and FloSeal . We measured relative and absolute bleeding times (seconds) as well as total blood loss (g) in a maximum observation time of 300 s. Sealants could show a significantly improved hemostasis comparing to the control group. However, hemostasis was heterogeneous among the sealant groups (liver resection: 60%-100%, spleen injury: 70%-100%). The mean blood loss decreased significantly using sealants comparing to control group (liver resection: 6-120 fold, spleen injury: 2.5-36 fold). The hemostatic time in groups that achieved complete hemostasis was different in each sealant group (liver resection: 30-166 s, spleen injury: 60-180 s). We conclude that the hemostatic efficacy of modern sealants is impressive but heterogeneous in liver resection or splenic lesion. To maximize the effectiveness of these tools, the indication of each sealant should be carefully considered in individual settings by the surgeons. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1307-1316, 2018.
肝膽手術過程中的肝實質切斷可能會破壞小血管或膽管,這可能很難處理。封合劑是實現更好止血的有用工具。本研究旨在分析四種現代封合劑在豬模型中的止血效率。
在本研究中,40 頭長白豬等分分為對照組(未使用封合劑)和四組封合劑組。進行標準化的肝切除和脾損傷,並未使用封合劑(對照組)或用以下一種封合劑處理:TachoSil、Tissucol Duo、Coseal 和 FloSeal。我們在最大觀察時間 300 秒內測量相對和絕對出血時間(秒)以及總出血量(克)。與對照組相比,封合劑可顯著改善止血效果。然而,封合劑組之間的止血效果存在差異(肝切除:60%-100%,脾損傷:70%-100%)。與對照組相比,使用封合劑可顯著降低平均出血量(肝切除:6-120 倍,脾損傷:2.5-36 倍)。在達到完全止血的各組中,止血時間在各封合劑組中不同(肝切除:30-166 秒,脾損傷:60-180 秒)。
我們得出結論,現代封合劑的止血效果令人印象深刻,但在肝切除或脾損傷中存在差異。為了最大限度地提高這些工具的有效性,外科醫生應在個體情況下仔細考慮每種封合劑的適應症。©2017Wiley Periodicals,Inc. J 生物醫用材料研究部分 B:應用生物材料,106B:1307-1316,2018。